| |
| | Prophylactic natural surfactant |
 | | Prophylactic intratracheal administration of natural surfactant extract in preterm infants at risk for developing RDS improves oxygenation (improved alveolar-arterial oxygen difference, improved arterial/alveolar oxygen ratio, decreased inspired oxygen concentration) and ventilation (decreased mean airway pressure, improved ventilator efficiency index) during the first 48-72 hours of life. |
 | | The meta-analysis suggests that prophylactic administration of natural surfactant extract leads to a significant decrease in the incidence of pneumothorax, pulmonary interstitial emphysema, neonatal mortality, and the incidence of bronchopulmonary dysplasia or death. |
 | | Infants who received prophylactic natural surfactant have a decreased incidence of respiratory distress syndrome, a decreased incidence of pneumothorax, a decreased incidence of pulmonary interstitial emphysema, a decreased incidence of neonatal mortality, and a decreased incidence of bronchopulmonary dysplasia or death. |
| www.nichd.nih.gov /cochrane/SOLL3/SOLL3.HTM (3504 words) |
|